[Federal Register Volume 71, Number 196 (Wednesday, October 11, 2006)]
[Notices]
[Page 59798]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-16721]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Meeting; Interagency Autism Coordinating Committee

    The National Institutes of Health (NIH) hereby announces a meeting 
of the Interagency Autism Coordinating Committee (IACC) to be held on 
November 17, 2006, on the NIH campus in Bethesda, Maryland.
    The Children's Health Act of 2000 (Pub.L. 106-310), Title I, 
Section 104, mandated the establishment of an Interagency Autism 
Coordinating Committee (IACC) to coordinate autism research and other 
efforts within the Department of Health and Human Services (DHHS). In 
April 2001, the HHS Secretary delegated the authority to establish the 
IACC to the National Institutes of Health (NIH). The National Institute 
of Mental Health (NIMH) at the NIH has been designated the lead for 
this activity.
    The IACC meeting will be open to the public, with attendance 
limited to space available. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the contact person listed 
below in advance of the meeting.
    Name of Committee: Interagency Autism Coordinating Committee.
    Date: November 17, 2006.
    Time: 9 a.m.-4 p.m.
    Agenda: Discussion of autism activities across Federal agencies.
    Place: National Institutes of Health, Building 31, Conference Room 
10 (6th floor), 31 Center Drive, Bethesda, Maryland 20892.
    Contact Person: Ann Wagner, Ph.D., Division of Pediatric 
Translational Research and Treatment Development, National Institute of 
Mental Health, NIH, 6001 Executive Boulevard, Room 6184, MSC 9617, 
Bethesda, Maryland 20892. E-mail: [email protected]. Phone: 301-443-
5944.
    Any member of the public interested in presenting oral comments to 
the Committee may notify the contact person listed on this notice at 
least 5 days in advance of the meeting. Interested individuals and 
representatives of organizations may submit a letter of intent, a brief 
description of the organization represented, and a short description of 
the oral presentation. Presentations may be limited to 5 minutes; both 
printed and electronic copies are requested for the record. In 
addition, any interested person may file written comments with the 
Committee by forwarding his/her statement to the contact person listed 
on this notice. The statement should include the name, address, 
telephone number, and, when applicable, the business or professional 
affiliation of the interested person.
    Information about the meeting and online registration forms are 
also available on-line on the NIMH homepage at http://www.nimh.nih.gov/autismiacc/index.cfm.

    Dated: September 29, 2006.
Raynard S. Kington, M.D., Ph.D.,
Deputy Director, National Institutes of Health.
 [FR Doc. E6-16721 Filed 10-10-06; 8:45 am]
BILLING CODE 4167-01-P